Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv 6/13/2025 Earnings Report

Pharma-Bio Serv logo
$0.48 -0.02 (-4.00%)
As of 06/4/2025 12:54 PM Eastern

Pharma-Bio Serv EPS Results

Actual EPS
N/A
Consensus EPS
$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Pharma-Bio Serv Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.00 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pharma-Bio Serv Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Pharma-Bio Serv Earnings Headlines

PBSV Returns to Growth
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Gold analyst, Sean Brodrick, gave everyday investors an advance notice of this historic surge. When the bull market was still in its infancy, he declared: "We're witnessing the start of what could be the biggest gold rush in history, one that could easily hand early investors spectacular gains."
See More Pharma-Bio Serv Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pharma-Bio Serv? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your email.

About Pharma-Bio Serv

Pharma-Bio Serv (OTCMKTS:PBSV) operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

View Pharma-Bio Serv Profile

More Earnings Resources from MarketBeat